Clearly, these studies have to be extended and repeated but future studies are needed to determine whether serum AMH alone or in combination with other gonadal markers such as inhibin B, testosterone, FSH, or insulin-like peptide 3 (INSL3) can be used to select infertile men suitable for medical interventions to improve sperm production and male fertility. The gene discussed is INSL3; the disease is male fertility.